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Abstract 
A biomaterial constituted by a metallic titanium alloy (TiAl6V4) coated with a bioglass 
layer (Na2O (7-24%), K2O (2-8%), CaO (9-20%), Al2O3 (0.1-2%), MgO (0.1-2%), SiO2 
(46-53%) and P2O5 (4-8%) was implanted in the cancellous bone of adult rabbit knee, 
in orthotopic situation, under conditions of mechanical stability.  
The animals were sacrificed after 30 (Group I), 90 (Group II), and 180 (Group III) days 
postoperatively. The bone pieces, containing the samples under investigation, were 
studied using radiographs, optical microscopy, scanning electron microscopy and 
electron probe micro-analysis. 
Radiologically, osteointegration of the implant surface was observed in all cases at the 
180th day after the surgery. A new bone formation was observed in the animals of 
Group I and the specimens observed after 90 days of the surgery (Group II) presented 
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a higher amount of new bone tissue. At the 180th day, the bioglass coating of the 
metallic titanium alloy was not detected and a total contact between the metallic 
surface and the new bone tissue was observed. The incorporation of the bioglass layer 
into the bone matrix occurred without interposition of non mineralized tissues and 
without the presence of inflammatory cells.  
These results strongly suggest that the studied ceramic coating material of the metallic 





Orthopaedic surgeons and basic scientists have translated advances of biomaterials 
science into novel management options for their patients. Implanted biomedical 
prosthetic devices are intended to perform safely, reliably, and effectively in the human 
body for prolonged periods of time. The development of cementless implants emerged 
as a natural evolution of the joint arthroplasty concept, allowing a direct confrontation 
of an artificial structure with an active biological environment in permanent remodeling, 
aiming at a precocious osteointegration and a successful joint replacement.  
Biomaterials are widely used in the composition of joint substitution prosthesis. Pure 
titanium implants are currently employed in ortopaedic surgery, as this metal offers the 
best available surface to interface and anchorage with the bone. Nevertheless, 10 years 
retrospective studies revealed osteolytic areas and implant failure when porous metallic 
surfaces were used. This type of problem has not yet been detected with 
hydroxyapatite coated hip prosthesis (1,2). Nevertheless, the main problem with these 
implants concerns the osteolytic mechanisms caused by the presence of wear particles. 
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Bioglass has been known for almost 20 years and it has been proven its excellent 
osteointegration behaviour. However, despite their good biocompatibility, only very few 
prosthesis with this ceramic material are implanted in orthopaedic surgery. A major 
drawback is their poor mechanical strength associated with a high production cost. On 
the other hand, bioglass formulations, in form of granules, fibers and blocks, are brittle 
and may form particular debris, contributing to the release of inflammatory cytokines 
(3).  
However, a single process was developed by which powdered granular bioglass is 
synthesized and applied by plasma spraying, opening the possibility of ortopaedic 
application as a coating implant, in the aim of a better bone anchorage. Exposing a 
metal substrate to the plasma allows the production of coatings, which are obtained 
with adhesion strengths over 30 MPa (4). The advantages of the plasma-spray 
technique include a high depositional velocity, a reduced alteration of the metallic 
substrate and a minimum dimensional tolerance. 
Certain glasses and glass-ceramics materials belong to the biologically active group 
of glasses, that, when placed in contact with cellular tissues, demonstrate good 
biocompatibility both in vivo and in vitro and an absence of inflammatory and toxic 
processes (5). Furthermore, in the presence of precursory osteogenetic conditions, they 
also demonstrate an osteoconductive predisposition, which tends to favor a particularly 
good biological bond at the interface between the glass and the bone tissues. 
Aditionally, certain bioactive glasses are able to connect to bone through a chemical 
bond (6). However, the bioactivity of a glass is compositional dependente (region A 
according to the ternary diagram of Hench (5)), and the rate, the strength and stability 
of the bond vary not only with the composition but also with the  microstructure of the 
bioactive material. 
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Since the epoch-making development and investigations of Bioglass® by Hench many 
publications and developments of comparable materials (7,8,9,10,11) have been 
reported. Nevertheless, works describing the clinical results of bioglass coated 
prosthesis are rarely found in orthopaedic literature (12). On the contrary, numerous 
experimental studies in vivo are currently under investigation (13,14,15,16). 
In order to evaluate the biological behavior of a biomaterial constituted by a metallic 
titanium alloy (TiAI6V4) coated with a bioglass layer, an experimental in vivo study was 
performed using rabbits. The implants were placed in orthotopic situation, in the 
cancellous bone of the rabbit knee, under conditions of mechanical stability. 
 
Experimental procedure 
A metallic titanium alloy (TiAl6V4) similar to those used for a human orthopaedic 
prosthesis with a cylindrical form (10 mm x 3mm) was submitted to a superficial 
treatment, following the spraying process. The bioglass coating, with a constant 
thickness of about 80 µm, was reasonably homogeneous with the presence of 
microcavities (Fig. 1). The implants were subsequently sterilised by gamma radiation.  
The bioglass (Biovetro®, Cgbdp Group), with an amorphous structure, had the 
following composition: Na2O (7-24%), K2O (2-8%), CaO (9-20%), Al2O3 (0.1-2%), MgO 
(0.1-2%), SiO2 (46-53%) and P2O5 (4-8%). 
Fifteen Californian rabbits, males 9 months old (body weight 3.600±0.020 Kg), were 
used in this study. 30 implants were impacted (“press-fit” technique) at the medial 
condyle of the femur, two in each rabbit, through a medial parapattelar approach. The 
animals were anesthetised by an i.m. injection of xylazine hydrochloride (Rompum® 
2%), 0.5ml/kg, and ketamine hydrochloride (Ketalar®) 0.37ml/Kg, under aseptic 
conditions. After the surgery the animals were allowed unrestricted movement in their 
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cages and were maintained according to the Portuguese law for animals (Portaria 
1005/92,  23/10 /1992). The rabbits were sacrificed with an overdose of ketamine 
hydrochloride at 30 (Group I), 90 (Group II), and 180 (Group III) days postoperatively. 
Each group corresponded to ten animals. The femora were resected just above the 
condyles, using a manual saw, and the soft tissue was removed. Preliminary, 8 implants 
were introduced in 4 animals in order to optimise the surgical technique and these 
rabbits were sacrificed at intervals of 7 and 15 days, after the implantation. 
The bone pieces, containing the samples under investigation, were fixed in buffered 
formaldehyde 4% and radiographed (Odel, Sirius 1000, 40-50 KV, 8-10 mAs). After this 
preliminary observation, undecalcified, methyl methacrylate embedded specimens were 
prepared. Sections with 30 µm thick were taken perpendicular to the longest implant 
axis (using a cutting-grinding technique) and then stained with both the van Gieson and 
the Toluidine Blue methods for histological examination. The histological sections were 
observed using optical microscope with polarized light, scanning electron microscopy 
and electron probe micro-analysis (EPMA). For the two latest techniques the samples 
were coated with a 300 nm thick gold layer deposited by sputtering. The analysis 
performed by EPMA consisted of chemical elemental distribution for calcium and silicium 
obtained with an accelerating voltage of 20 keV and a beam current of 100 nA. 
 
Results and Discussion 
Radiologically, no lucent lines were detected in the bone-implant interface in the 
three experimental groups. At the 180th day after the surgery, osteointegration of the 
implant surface was observed in all cases (Fig. 2).  
The preliminary studies enabled to detect, as early as the 15th postoperative day, by 
microscopic observation of the implant, the formation of new bone on the implant 
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surface as a diffuse interface without cleavage zones and without the interposition of 
fibrous tissue (Fig. 3). These findings are characteristics of an osteocoalescence process 
and are more evident at 30th and 90th days. These observations indicate that there is a 
strong chemical bond between the bioglass material and bone living tissue, revealing a 
good bioactivity of the bioglass. On the other hand, neither the presence of fibrous 
encapsulation nor the infiltration of inflammatory cells was detected in any of the 
implants. 
In Group I the new bone formation directly contacting the bioglass layer or the metal 
alloy was observed on the same analyzed specimen (Fig.4). In the animals of Group II, 
and as expected, more new bone tissue was detected when compared to that present 
after 30 days. At the 180th day after implantation, non bioglass areas were observed 
and a total contact between the metallic surface and the new bone tissue was found 
(Fig.5). Moreover, neither a corrosion process, located on the surface of the metallic 
titanium alloy, nor the presence of delaminating on the bioglass layer were observed. 
The elemental X-ray distributions maps obtained by EPMA, for silicium and calcium, 
confirmed the observations of light microscopy. In fact, a decrease of Si (corresponding 
to bioglass layer) accompanied by an increase of Ca content (corresponding to new 
bone formation) was found at the implant interface (Fig.6). 
As mentioned before, in this work the implants were introduced under mechanical 
stability, in a well-vascularized bone environment, although there was no direct loading 
of the implant. The lack of direct loading may negatively affect new bone formation. 
Nevertheless, the microcopic studies showed an increase of new bone formation with 
increasing implantation time which can be due to the following factors. 
 The physiologic mechanical stress may have affected the incorporation of the 
bioglass layer because a new bone formation, originated from the host, was observed  
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on the implant surface, initially with characteristics of immaturity (woven bone), 
followed by physiological process of bone remodeling and bone maturation.  
On the other hand, the roughness of the implant surface as well as its chemical 
composition favorably influenced the bone reaction, leading to an early bone ingrowth 
and mechanical fixation as been shown by other authors (2). In fact, at 15th 
postoperative day, a process of new host bone formation on the bioglass layer in a firm 
union was observed, without interposition of fibrous tissue, suggesting a chemical 
bonding between the implant surface and the new formed bone. Furthermore, neither 
the interposition of fibrous tissue nor the presence of inflammatory cells was detected.  
After 180 days, and as Figure 6 illustrates, the metallic titanium alloy contacted 
directly with the bone tissue, on most of its extension, through a contact osteogenesis 
process, without interposition of a non mineralized tissues. The bioglass layer was 
almost completely reabsorbed and gradually replaced by new host living bone, 
indicating the incorporation of the implant surface without the interposition of 
connective tissue. These observations demonstrate that the implant surface is 
bioresorbable. 
        The in vivo studies carried out in this work have shown that throughout the 
experimental time a gradual and controlled reabsorption of the bioglass layer and a  
new bone ingrowth in direct contact with the metallic titanium alloy. According to the 
literature, this is the result of the reaction between the surface of the bioactive glass 
with the host tissue, on the implantation site, leading to the formation of a gel with an 
ion composition similar to that of the ossification front formed during natural bone 
remodeling allows its recognition, by osteoblasts, as a substrate for the deposition of 
bone matrix (11,19). 
In conclusion, the above results demonstrate that the studied ceramic coating 
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material is bioactive, biocompatible, bioresorbable and possesses osteoconductive 
properties. Such characteristics open new perspectives for clinical and experimental 
studies. Furthermore the use of a bioglass layer as a carrier of bone growth factors can 
accelerate the osteointegration of an implant with an identical composition. 
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        a)                                                      b) 
Fig.1 – SEM micrographs of the implant: a) transverse section of the metallic titanium 






Fig. 2 – Radiograph image of an implant after 180 days of insertion, showing 





Fig. 3 – Light micrograph of an implant at 15th day. A processof new host bone 
formation (NB) on the bioglass layer (B) in a firm union was observed, without 





Fig. 4 - Light micrograph of an implant at 30th day. Note the new bone was in some 
areas contacting directly with the bioglass layer (B) and in others contacting with the 









Fig. 5 - Light micrograph of an implant at 180th day, showing a direct contact between 
the new host bone tissue and the metallic titanium alloy. Neither a bioglass layer nor a 
connective tissue was observed (Undecalcified section stained with Toluidine Blue, 







Fig. 6 – a) Elemental X-ray distribution map obtained by EPMA of an implant at 15th day 
after the surgery showing areas with high Si content (S) at bone/implant interface b) At 
90th day a low Si content and a high Ca content were found. c) At 180th day a Calcium 
based structure (bone tissue (B)) was detected, in direct contact with the metallic 
titanium alloy (T). 
 
 
